Back
NovaBay Pharmaceuticals Stock Predictions
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
0.72
Seasonality Move:
-14.79%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.NovaBay Pharmaceuticals Stock Forecast
-
Is NovaBay Pharmaceuticals Stock Undervalued?
The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal. - NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will NovaBay Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
NovaBay Pharmaceuticals Stock Rating
Data Unavailable
NovaBay Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novabay.com
52-Week Data
52-Week High:
17.74
52-Week Low:
0.36
Prediction Charts
Market Cap:
3.62M
Price in USD:
0.74
Volume:
144.66M
Beta:
1.34
Technical Analysis
SMA50:
0.83
SMA100:
1.96
SMA200:
3.74
52-Wk Change:
-95.22%
Stock Predictions
-
Is NovaBay Pharmaceuticals stock public?
Yes, NovaBay Pharmaceuticals is a publicly traded company. -
What is the NovaBay Pharmaceuticals stock quote today?
The NovaBay Pharmaceuticals stock price is 0.74 USD today. -
How to buy NovaBay Pharmaceuticals stock online?
You can buy NovaBay Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 0.47 | 0.48 | 0.50 | 0.44 |
| Sep-4 | 0.49 | 0.48 | 0.49 | 0.46 |
| Sep-5 | 0.46 | 0.47 | 0.49 | 0.46 |
| Sep-6 | 0.47 | 0.45 | 0.49 | 0.45 |
| Sep-9 | 0.45 | 0.46 | 0.46 | 0.44 |
| Sep-10 | 0.44 | 0.46 | 0.46 | 0.44 |
| Sep-11 | 0.45 | 0.48 | 0.49 | 0.45 |
| Sep-12 | 0.48 | 0.47 | 0.49 | 0.46 |
| Sep-13 | 0.50 | 0.47 | 0.50 | 0.47 |
| Sep-16 | 0.50 | 0.49 | 0.50 | 0.47 |
| Sep-17 | 0.50 | 0.53 | 0.54 | 0.48 |
| Sep-18 | 0.53 | 0.51 | 0.54 | 0.50 |
| Sep-19 | 0.51 | 0.50 | 0.52 | 0.49 |
| Sep-20 | 0.87 | 0.74 | 1.01 | 0.62 |
NovaBay Pharmaceuticals Earnings
Data Unavailable
NovaBay Pharmaceuticals Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.